We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Automated Enzymatic Method Quantifies Pyruvate Kinase in Erythrocytes

By LabMedica International staff writers
Posted on 05 Mar 2020
A deficiency of red blood cell (RBC) pyruvate kinase (PK), inherited as an autosomal recessive trait, is the most common cause of hereditary nonspherocytic hemolytic anemia (HSHA). More...
The hemolysis is owing to the inability of the PK-deficient RBCs to maintain adequate quantities of ATP.

Pyruvate kinase (PK) deficiency affects less than 1% of the population. As the most common cause of HSHA, testing for PK activity is commonly performed. PK activity is generally greater in reticulocytes than in mature RBCs and may explain the appearance of hemolytic anemia in patients with normal enzyme activity.

Scientists at the ARUP Institute (Salt Lake City, UT, USA) collected residual whole blood samples collected into tubes containing EDTA or heparin anticoagulant and sent to ARUP Laboratories were used after being deidentified. Because white blood cells contain 300 times the PK activity of RBCs, the two cell types were separated from each other and the plasma by using phthalate oil in a glass capillary tube that was centrifuged at 9,600g for five minutes and hemolysates were prepared.

PK activity was determined using a method proposed by the International Committee for Standardization in Hematology. PK catalyzes the reaction of phosphoenolpyruvate with ADP to form pyruvate and ATP. The pyruvate is reduced in the presence of lactate dehydrogenase and NADH to produce lactate and NAD+. For the manual method, the rate of absorbance decrease at 340 nm was determined using a Cary 60 spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) and was used to derive the PK activity in conjunction with the molar absorptivity of 6,220 L/mol/cm. PK and hemoglobin (Hb) measurements were performed on a Roche cobas c501 analyzer (Roche Diagnostics, Basel, Switzerland).

The scientists reported that the accuracy of the automated PK assay was evaluated by comparing it with the manual method with 56 samples measured in two replicates over 10 days. PK activities ranged from 1.5 to 25.9 U/g Hb, and linear regression produced a slope where R2 = 0.93, indicating that the two methods produced the same results. Precision was evaluated by testing hemolysates in three replicates/day for 10 days. Within-run imprecision was 1.9% and 2.5% and total imprecision was 4.0% and 5.6% at 14.0 and 8.1 U/g Hb, respectively. The limit of blank was 0.0, and the limit of detection was 1.0 U/dL. Stability was determined in four sample types at three different temperatures; the changes were all was less than 10% when compared with t0. The current PK reference interval of 4.6 to 11.2 U/g Hb was verified.

The authors concluded that the ability to measure both components on a single automated platform and in the same hemolysate is an efficient method to replace a manual activity assay using two different analytical platforms. The study was published in the January 2020 issue of The Journal of Applied Laboratory Medicine.


Related Links:
ARUP Institute
Agilent Technologies
Roche Diagnostics



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.